20 In a Duchenne muscular dystrophy study, the primary endpoint of safety was met, and the study showed a trend for maintenance of the 6 min walk test, lean body mass, and bone mineral density versus placebo without reaching statistical significance. 21 Atara Biotherapeutics PINTA745 showed good efficacy in a stroke mouse model, in which it attenuated loss of body weight and improved body weight recovery after cerebral ischaemia.
1
—
—